Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
105.00    1.80 (1.74%)
Bid:
104.40
Ask:
105.20
Spread: 0.80 (0.766%)
Market Cap: £172.14m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Update

29 Dec 2008 07:00

RNS Number : 7991K
Yule Catto & Co PLC
29 December 2008
 



29 December 2008

Yule Catto & Co plc

Update

Yule Catto & Co plc ("the Group") is pleased to announce that it has signed a new three year £30 million revolving loan facility with its principal banks, HSBC and Barclays. This loan replaces its existing revolving bank loan facility maturing in November 2009.

During the course of this re-financing, the Board has been carefully considering the capital structure of the Group.  Whilst much progress has been made on the deleveraging of the balance sheet, with £55 million of gross proceeds received from the sale of three of our five Impact Chemicals businesses, the balance sheet remains a core focus of the Board and it aims to reduce outstanding net debt to below £100 million over the next twelve to twenty four months. The Board believes this is consistent with the Group's objectives, including its financial commitments to the Group's UK pension fund.

Accordingly, and in light of the current financial environment and economic uncertainty, the Board has additionally decided to suspend the payment of dividends until such time as net debt is nearer to its overall target and at which time the business environment and financial market conditions may well have improved. The Board anticipates reverting to the payment of a dividend within two years.

At the time the Group recommences the payment of a dividend, the Board anticipates rebasing it to a level determined by comparison with its peer group and which will allow an appropriate free cash flow to suit the Group's circumstances.

The Board is also pleased to confirm that for 2008 the Group still expects to deliver underlying earnings before tax modestly ahead of last year, despite the current difficult economic conditions particularly in the UK and Continental Europe.

The Board believes it is too early at this time, given the prevailing economic uncertainty, to offer any firm guidance on the outturn for 2009.  The Group's Impact Chemicals and Pharma Chemicals businesses should benefit next year from recent restructuring.  Within our Polymer Chemicals business we anticipate the performance of our Asian and Middle East businesses to be more robust than that of our European businesses, due to local market conditions and a more resilient demand profile from our targeted markets. In addition, the current relative weakness of Sterling against the Dollar, Euro and Malaysian Ringgit, should it continue, will assist the reported Sterling earnings for a number of our businesses.

The Group continues to look at ways to improve efficiency and minimise costs. We currently have a number of initiatives in hand to do this, both within Europe and the rest of the world. 

These are exceptional times, with a high degree of market uncertainty and a very difficult environment for funding.  Having completed £55 million of divestments and put in place a new revolving loanthe Board believes that, together with internal actions to conserve cash and the suspension of the dividend, Yule Catto is now well placed to weather these conditions.

- Ends -

For further information, please contact:

Yule Catto & Co plc
Adrian Whitfield, Chief Executive
David Blackwood, Group Finance Director
 
01279 442791
Hogarth Partnership 
John Olsen
Andrew Jaques
Ian Payne
020 7357 9477
07770 272082

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKQKNNBDDFBB
Date   Source Headline
12th May 20113:51 pmRNSResult of AGM
12th May 20117:00 amRNSInterim Management Statement
4th May 20113:17 pmRNSAnnual Information Update
3rd May 20111:30 pmRNSHolding(s) in Company
28th Apr 201112:28 pmRNSHolding(s) in Company
21st Apr 20113:24 pmRNSDirector/PDMR Shareholding
21st Apr 20113:19 pmRNSDirector/PDMR Shareholding
7th Apr 20113:00 pmRNSHolding(s) in Company
7th Apr 201110:01 amRNSHolding(s) in Company
7th Apr 20119:15 amRNSAnnual Financial Report
31st Mar 20113:48 pmRNSAcquisition
30th Mar 20114:38 pmRNSHolding(s) in Company
18th Mar 20114:28 pmRNSHolding(s) in Company
15th Mar 20111:42 pmRNSHolding(s) in Company
15th Mar 201110:15 amRNSHolding(s) in Company
14th Mar 201111:22 amRNSHolding(s) in Company
14th Mar 201111:20 amRNSEBT Share Purchase
9th Mar 20117:00 amRNSFinal Results
8th Mar 201111:58 amRNSHolding(s) in Company
8th Mar 20119:17 amRNSDirector Declaration
2nd Mar 20114:47 pmRNSHolding(s) in Company
2nd Mar 201110:27 amRNSAcquisition
15th Feb 20119:40 amRNSAcquisition of Polymer Latex
31st Jan 201112:16 pmRNSDirector/PDMR Shareholding
31st Jan 201111:50 amRNSTotal Voting Rights
20th Jan 201111:26 amRNSHolding(s) in Company
20th Jan 201111:24 amRNSHolding(s) in Company
18th Jan 20114:19 pmRNSHolding(s) in Company
18th Jan 20119:58 amRNSResult of Equity Issue
17th Jan 20115:28 pmRNSResult of Equity Issue
14th Jan 20111:21 pmRNSHolding(s) in Company
13th Jan 20114:33 pmPRNCorrection : Disclosure of Short Position
5th Jan 201112:15 pmRNSDirector/PDMR Shareholding
4th Jan 20111:03 pmRNSHolding(s) in Company
30th Dec 201011:31 amRNSResult of EGM
16th Dec 20105:15 pmRNSHolding(s) in Company
16th Dec 20105:13 pmRNSHolding(s) in Company
16th Dec 20105:05 pmRNSHolding(s) in Company
13th Dec 20105:12 pmRNSPublication of Prospectus
13th Dec 20107:00 amRNSAcquisition and Rights Issue
23rd Nov 201011:42 amRNSHolding(s) in Company
11th Nov 20107:00 amRNSInterim Management Statement
16th Sep 20109:37 amRNSHolding(s) in Company
14th Sep 201010:31 amRNSHolding(s) in Company
26th Aug 20105:42 pmRNSAppointment of Senior Independent Director
26th Aug 20107:00 amRNSHalf Yearly Report
28th Jun 20101:18 pmRNSDirectorate Change
24th Jun 20107:00 amRNSPre-close Trading Update
2nd Jun 20108:54 amRNSCompletion of disposal
6th May 201012:32 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.